Fact CheckerSign in

NCT04836715Completed

Prevalence of Visual Dysfunction in Neurological Disorders

Prevalence of Visual Dysfunction in Persons With Parkinson's Disease and Other Neurological Disorders

Source: ClinicalTrials.gov · Last updated 12 Jun 2024

Brief summary (registry, in English)

The objective is to determine the prevalence of visual dysfunction in People with Parkinson's Disease (PwP). The investigators will administer the: Visual Impairment in Parkinson's Disease Screen and Revised-Self-Report Assessment of Functional Visual Performance. Patients seen at Fixel Institute and their caregivers will be invited to participate. Responses to the 2 questionnaires will help determine prevalence rates of visual dysfunction in PwP compared to those both with and without other neurological conditions.

Status (registry)
Completed
Study type
Observational
Enrollment
92 (actual)
First submitted
5 Apr 2021
Start date
Jan 2021
Primary completion date
Dec 2023
Lead sponsor
University of Florida
NCT number
NCT04836715

What you commit to

  • Study type: Observational
  • Participants enrolled: 92
  • From Jan 2021 to the primary completion date, Dec 2023
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Persons with more than one diagnosed neurological condition.

Age

  • Children (ages younger than 18 years of age)

Who the study is looking for

  • Persons with Parkinson's Disease: Confirmed diagnosis of Parkinson's Disease without presence of any other neurological condition.
  • Persons without Parkinson's Disease (Controls): No previous diagnosis of any neurological condition
  • Persons with a single other neurological disorder (Neuro Controls): Confirmed diagnosis of other neurological condition (e.g. ALS, multiple sclerosis, essential tremor, ataxia, etc).

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Florida
Coordinator of this site? Confirm its status
GainesvilleUnited StatesUnknown status
UF Health Rehab - Fixel Institute
Coordinator of this site? Confirm its status
GainesvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.